Glomerular disturbances in preeclampsia: Disruption between glomerular endothelium and podocyte symbiosis

Hypertension in Pregnancy

Volumn 29, Issue 1, 2010, Pages 10-20

  Henao, Daniel E ^a   Saleem, Moin A ^b   Cadavid, Ángela P ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Glomerular endothelium; Podocytes; Preeclampsia; Proteinuria; SFlt 1; Symbiosis; VEGF

Indexed keywords

ACTIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BEVACIZUMAB; CD2 ASSOCIATED PROTEIN; ENDOTHELIN 1; NEPHRIN; NEUROPILIN 1; PODOCIN; SYNAPTOPODIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC ACTIVITY; CLINICAL FEATURE; ENDOTHELIUM; GLOMERULAR DYSFUNCTION; GLOMERULAR ENDOTHELIOSIS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HUMAN; HYPERTENSIVE CRISIS; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; PHENOTYPE; PLACENTA DISORDER; PODOCYTE; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEINURIA; REVIEW; SYMBIOSIS; VASCULAR ENDOTHELIUM;

ENDOTHELIUM; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY;

EID: 75749108585     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950802631036     Document Type: Review

References (31)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183(1):S1-S22.
2. Maynard SE, Min JY, Merchan J, et al.. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649-658.
3. Levine RJ, Maynard SE, Qian C, et al.. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672-683.
4. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007; 18(8):2281-2284.
5. Hladunewich MA, Myers BD, Derby GC, et al.. Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol 2008; 294(3):F614-620.
6. Singh A, Satchell SC, Chris R. Neal, et al.. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18:2885-2893.
7. Garovic VD, Wagner SJ, Petrovic LM, et al.. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007; 22(4):1136-1143.
8. Collino F, Bussolati B, Gerbaudo E, et al.. Pre-eclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008; 294(5):F1185-94.
9. Henao DE, Arias LF, Mathieson PW, et al.. Preeclamptic sera directly induce slit diaphragm protein redistribution and alter podocyte barrier forming capacity. Nephron Experimental Nephrology 2008; 110(3):e73-81.
10. Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288(1):F48-57.
11. Guan F, Villegas G, Teichman J, Mundel P, Tufro A. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal Physiol 2006; 291(2):F422-428.
12. Eremina V, Jefferson JA, Kowalewska J, et al.. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358(11):1129-1136.
13. Strevens H, Wide-Swensson D, Hansen A, et al.. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003;, 110(9):831-836.
14. de Swiet M, Lightstone L. Glomerular endotheliosis in normal pregnancy and preeclampsia. BJOG 2004; 111:191-195.
15. Henao DE, Mathieson PW, Saleem MA, Bueno JC, Cadavid A. A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant 2007; 22(5):1477.
16. Tryggvason K, Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001; 10(4):543-549.
17. Garovic VD, Wagner SJ, Turner ST, et al.. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007; 196(4):320, e321-327.
18. Karumanchi SA, Lindheimer MD. Preeclampsia and the kidney: footprints in the urine. Am J Obstet Gynecol 2007; 196(4):287-288.
19. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308(5728):1592-1594.
20. Sugimoto H, Hamano Y, Charytan D, et al.. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278(15):12605-12608.
21. Eremina V, Sood M, Haigh J, et al.. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111(5):707-716.
22. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168(2):639-648.
23. Foster RR, Hole R, Anderson K, et al.. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003; 284(6):F1263-1273.
24. Feng D, Nagy JA, Brekken RA, et al.. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000; 48(4):545-556.
25. Harper SJ, Xing CY, Whittle C, et al.. Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond) 2001; 101(4): 439-446.
26. Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem 2000; 275(35):26690-26695.
27. Li Z, Zhang Y, Ying Ma J, et al.. Recombinant Vascular Endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007; 50:686-692.
28. Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development 2008; 135(4):609-620.
29. Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331(2):485-493.
30. Satchell SC, Tasman CH, Singh A, et al.. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006; 69(9):1633-1640.
31. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88(2):451-487.